Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The target refers to a collection of proteins within the proximal renal tubule of the renal cortex that possess accessible free sulfhydryl (thiol) groups (Zalups, 2000, Pharmacological Reviews). These groups are highly reactive and serve as the primary binding sites for heavy metals, most notably inorganic mercury (Hg2+), and historical organomercurial diuretics (Lash et al., 2000, Environmental Health Perspectives). Binding to these sulfhydryl groups typically results in the covalent modification and subsequent inhibition of essential cellular components, including transport proteins such as the Na+/K+-ATPase and various metabolic enzymes (Miller, 1992, Toxicology). This interaction disrupts ion reabsorption and cellular homeostasis, leading to the diuretic effect of organomercurials or, in the case of heavy metal exposure, significant nephrotoxicity and acute tubular necrosis (StatPearls, 2023). While historically significant in the development of diuretics, these sites are now primarily studied in the context of toxicology and environmental health (Bridges & Zalups, 2017, Journal of Toxicology and Environmental Health). Therapeutic strategies often involve the use of chelating agents like dimercaprol that compete for metal ions, thereby protecting these critical protein thiols from irreversible damage (PubChem, 2024).
Covalent binding to sulfhydryl groups of renal tubular proteins, inhibiting enzymes and transporters involved in sodium reabsorption (e.g., Na+/K+-ATPase).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proximal renal tubule sulfhydryl-containing proteins.